To further determine that chidamide could downregulate MCL1 and overcome venetoclax resistance, we then evaluated antiapoptotic protein expression in different tested AML cell lines which were purchased from ATCC (Manassas, US). The gene discussed is MCL1; the disease is acute myeloid leukemia.